NCT01995136View on ClinicalTrials.gov

Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Normal Tension GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost Ophthalmic Solution 0.004%

benzalkonium chloride (BAC) free

Trial Locations (1)

Unknown

Alcon Japan, Ltd., Tokyo

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01995136 - Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma | Biotech Hunter | Biotech Hunter